Milk leg is an old term for a painful, swollen, pale-white leg caused by a large blood clot blocking the deep veins, most often in the weeks after childbirth. The medical name is phlegmasia alba dolens, Latin for “painful white inflammation,” and the condition is a severe form of deep vein thrombosis (DVT). The name “milk leg” comes from an outdated belief that breast milk somehow backed up into the leg, causing the swelling and whiteness. While the folklore has long been discarded, the condition itself remains a real and serious complication that still occurs today, and not exclusively in new mothers.
Where the Name Came From
In the eighteenth and nineteenth centuries, physicians noticed that some women developed dramatically swollen, white, painful legs shortly after giving birth. Because the timing coincided with the onset of breastfeeding, the dominant theory was that milk was being diverted or “metastasized” into the limb. The condition became known as milk leg, or in French medical literature, “phlegmatia alba dolens lactea.” It was only in the mid-1800s that the real cause, venous thrombosis, was identified through autopsy studies. The folk name stuck in common usage long after the milk theory was abandoned, and you can still find it in patient-facing medical materials today.
Why Pregnancy and Childbirth Are the Classic Triggers
The link between milk leg and childbirth is not accidental. Pregnancy produces a convergence of factors that dramatically increase the risk of blood clots forming in the deep veins. The body ramps up its production of clotting factors during pregnancy as a protective measure against hemorrhage during delivery, blood volume increases substantially, and the growing uterus presses on the pelvic veins, slowing the return of blood from the legs. After delivery, the risks do not immediately subside. Clot risk actually peaks in the first few weeks postpartum.
Specific factors that push the risk higher include cesarean delivery, postpartum infection, obesity combined with bed rest, and an underlying inherited tendency toward abnormal clotting known as thrombophilia, which is present in more than half of pregnancy-related clot cases.1Europe PMC. Venous Thromboembolism During Pregnancy and the Postpartum Period: Risk Factors, Diagnostic Testing, and Treatment Women who have had a prior clot, who are on prolonged bed rest, or who undergo emergency surgery are at the highest end of the spectrum. The combination of these factors explains why, historically, milk leg was almost synonymous with the postpartum period.
It Does Not Only Happen After Childbirth
While the name milk leg implies a strictly obstetric condition, phlegmasia alba dolens can occur in anyone with a severe enough blockage of the deep veins. Cancer is one of the more common non-obstetric triggers, because tumors can compress veins directly and also push the blood into a hypercoagulable state. Major surgery, prolonged immobilization, and certain inherited clotting disorders are other well-established causes. In one reported case, a 39-year-old patient with a protein S deficiency developed the condition after a previously placed filter device inside the inferior vena cava became blocked by clot, causing massive backup into both legs.2PubMed. Inferior Vena Cava Filter Occlusion Causing Phlegmasia Alba Dolens
An anatomical quirk called May-Thurner syndrome also predisposes certain people to the condition. In this variant, the left iliac vein in the pelvis is compressed by the artery that crosses over it, slowing blood flow on that side and setting the stage for clots to form.3PubMed Central. Extensive Left Lower Limb Deep Vein Thrombosis Secondary to May-Thurner Syndrome in a Young Female In a large registry of patients with confirmed proximal DVT, about 4% were found to have May-Thurner syndrome, and these patients were disproportionately female, younger than average (mean age around 42 versus 62), and overwhelmingly presented with clots on the left side.4PubMed. Clinical Characteristics and Impact of May-Thurner Syndrome in Patients With Proximal Deep Vein Thrombosis: Insights From the RIETE Registry If you have ever heard that DVT is more common in the left leg, May-Thurner syndrome is a big part of the reason.
How to Recognize It
Milk leg has a distinctive presentation that separates it from a more routine blood clot. The hallmark features are:
- Severe swelling: The entire leg, from groin to ankle, becomes markedly enlarged, sometimes doubling in circumference over hours to days.
- Pale or white appearance: The skin turns a chalky white because the swelling compresses the small arteries near the surface, reducing blood flow to the skin. This pallor is the origin of “alba” in phlegmasia alba dolens.
- Intense pain: The leg is painful to touch and with movement, often described as a deep, heavy aching or throbbing.
- Taut, shiny skin: The skin may appear stretched and glossy from the degree of swelling.
The combination of pain, swelling, and whiteness distinguishes phlegmasia alba dolens from its more dangerous cousin, phlegmasia cerulea dolens, in which the leg turns blue or purple. The blue variant indicates an even more complete blockage, cutting off both venous outflow and arterial inflow, and it can progress to tissue death if not treated urgently. Milk leg, or the white variant, is considered a precursor state. If the clot burden increases and venous pressure rises further, it can transition to the blue form. Recognizing milk leg early is therefore critical because treatment at this stage can prevent the condition from worsening into something limb-threatening.
How Milk Leg Is Diagnosed
Diagnosis starts with the clinical picture. A massively swollen, white, painful leg in a postpartum woman, a surgical patient, or someone with cancer raises immediate suspicion. The standard confirmatory test is a duplex ultrasound, which uses sound waves to visualize blood flow in the veins and can identify where a clot is located and how extensive it is. In some cases, especially when the clot extends into the pelvic veins where ultrasound has limited visibility, CT venography or MR venography may be used to get a fuller picture of the obstruction.
For patients where May-Thurner syndrome is suspected as the underlying cause, cross-sectional imaging of the pelvis is particularly important. The compression of the left iliac vein by the overlying artery can be subtle on ultrasound, and identifying it changes how treatment is planned because a structural problem may require a stent in addition to clot removal.
Treatment With Blood Thinners
The foundation of treatment for any deep vein thrombosis, including milk leg, is anticoagulation, meaning drugs that slow the blood’s ability to form new clots and allow the body’s own systems to gradually dissolve the existing one. In pregnant and postpartum women, the drug of choice is low-molecular-weight heparin (LMWH), an injectable blood thinner that does not cross the placenta and has not been linked to harm to the fetus. Compared to older forms of heparin, LMWH causes fewer bleeding complications, carries a lower risk of a dangerous side effect called heparin-induced thrombocytopenia, and is easier to dose because it does not need constant blood-test monitoring.5Thrombosis Research. Management of venous thromboembolism in pregnancy – Section: Low molecular weight heparin (LMWH)
Outside of pregnancy, oral blood thinners such as warfarin or the newer direct oral anticoagulants (DOACs) are also options, and the choice depends on the patient’s other medical conditions, kidney function, and what stage of treatment they are in. Anticoagulation typically continues for at least three to six months, though some patients need it indefinitely if they have an ongoing risk factor like cancer or a permanent clotting disorder.
When Blood Thinners Are Not Enough
Milk leg involves a large clot burden, and in many cases, blood thinners alone do not resolve the blockage quickly enough to prevent lasting damage. The concern is that prolonged obstruction of the major veins causes sustained high pressure in the leg, which can permanently damage the valves inside the veins and lead to chronic swelling, skin changes, and pain for years afterward. For this reason, more aggressive approaches are often considered.
The main interventional options include catheter-directed thrombolysis, where a thin tube is threaded into the clot and clot-dissolving medication is delivered directly to the blockage, and percutaneous mechanical thrombectomy, where a device physically breaks up and removes the clot.6International Journal of Surgery Case Reports. Case report of simultaneous phlegmasia cerulea dolens and acute limb ischemia These procedures carry risks of their own, including damage to the vein lining and the possibility that fragments of clot may travel to the lungs during the procedure. Still, for severe cases, anticoagulation alone may be inadequate, and more aggressive clot removal is warranted.7PubMed Central. Successful treatment of phlegmasia cerulea dolens with percutaneous thrombectomy and catheter-directed thrombolysis: A case report
When an underlying structural problem like May-Thurner syndrome is identified, stenting of the compressed vein is often performed at the same time as clot removal to prevent the clot from re-forming. In a series of patients treated with single-stage thrombectomy and stenting for severe venous clots caused by iliac vein compression, all procedures were technically successful, symptoms improved in every patient, and at one year the stent remained open in about 82% of cases with no cases of severe long-term vein damage.8PubMed. Single-Stage Endovascular Thrombectomy and Stenting as the First-Line Strategy in the Treatment of Phlegmasia Cerulea Dolens Caused by Iliac Vein Lesions
Breastfeeding Considerations During Treatment
For postpartum women, the timing of milk leg overlaps with the early breastfeeding period, which creates a practical dilemma: how do you treat a blood clot safely while nursing? LMWH, the standard first-line treatment, is considered compatible with breastfeeding because it is a large molecule that is poorly absorbed orally and does not pass into breast milk in meaningful amounts.
The picture gets more complicated if a woman transitions to an oral blood thinner after the immediate postpartum period. Among the newer DOACs, safety during lactation varies. One drug, apixaban, accumulates in breast milk at concerning levels, with a relative infant dose that may reach around 21%, well above the 10% threshold generally considered acceptable. Two others, rivaroxaban and dabigatran, appear to transfer into milk at much lower levels, falling comfortably under that safety cutoff.9Quality in Sport. Methodological Limitations in Assessing the Safety of Direct Oral Anticoagulants During Lactation The evidence on a fourth agent, edoxaban, is extremely limited. For breastfeeding women who need to switch from injections to an oral blood thinner, these distinctions matter, and the conversation with your doctor should specifically address which drug is being prescribed.
Long-Term Consequences
Even with successful treatment, milk leg can leave a lasting mark. The most common long-term complication is post-thrombotic syndrome (PTS), a condition where the damaged veins and their valves never fully recover. Symptoms of PTS include chronic leg swelling that worsens throughout the day, skin discoloration around the ankles, a heavy or achy feeling in the affected leg, and in severe cases, skin ulcers that are difficult to heal. The severity varies widely. In one study comparing treatment approaches for proximal DVT with phlegmasia alba dolens, a meaningful proportion of patients continued to experience moderate to severe venous outflow problems at follow-up, though more aggressive treatment appeared to shift the balance toward milder outcomes.10Journal of Experimental and Clinical Surgery. Improvement of Medical Treatment Options of Proximal Deep Vein Thrombosis of Low Extremities Associated with Phlegmasia Alba Dolens
Post-thrombotic syndrome is one reason why there is growing interest in early clot removal rather than relying on blood thinners alone. The logic is straightforward: the sooner the clot is cleared and normal flow is restored, the less time the vein valves spend under destructive pressure. This does not guarantee a PTS-free outcome, but it improves the odds. A UK cost-effectiveness analysis found that mechanical thrombectomy for major leg vein clots, despite higher initial costs, actually resulted in lower lifetime costs and better quality of life compared with anticoagulation alone, primarily by reducing the long-term burden of PTS.11PubMed. Cost Effectiveness of Mechanical Thrombectomy Versus Anticoagulation for Treating Iliofemoral Deep Vein Thrombosis in the UK
Prevention in High-Risk Situations
For women at elevated risk during pregnancy or after delivery, prevention focuses on keeping blood moving through the leg veins. Graduated compression stockings are a simple, non-drug measure that works by applying gentle pressure from the ankle upward, squeezing blood through the deep veins more efficiently. Research in postpartum women has confirmed this effect directly: applying thigh-length compression stockings within a day or two of vaginal delivery significantly increased the speed of blood flow in the deep veins of the leg and reduced vein diameter, both signs of reduced stasis.12PubMed. The effect of graduated compression stockings on blood velocity in the deep venous system of the lower limb in the postnatal period Similar findings have been observed in pregnant women with leg swelling during late pregnancy, where compression stockings increased venous velocity and flow.13PubMed Central. The Effect of Wearing Elastic Compression Stockings on Leg Edema in Pregnant Women in Late Pregnancy as Determined by Measuring the Deep Venous Velocity and Flow
For women judged to be at higher risk because of prior clots, known thrombophilia, or multiple risk factors stacking up, preventive doses of LMWH during pregnancy and the postpartum period may be recommended. The decision to use preventive blood thinners is individualized, weighing the bleeding risks of the medication against the clot risks of the patient’s particular situation. Early mobilization after delivery, staying well hydrated, and avoiding prolonged bed rest are additional common-sense measures that complement any medical prophylaxis.
The Emotional Side
The physical symptoms of milk leg tend to dominate the clinical conversation, but for postpartum women the psychological fallout can be significant. Developing a serious medical complication during what is supposed to be a time of bonding with a newborn is distressing. Pain and immobility may interfere with holding, feeding, and caring for the baby. Research into the experience of pregnancy-related blood clots suggests that the condition can negatively affect maternal wellbeing and the bonding process, and may increase the risk of anxiety and depression.14ScienceDirect (Thrombosis Research). Patient experience of pregnancy-related venous thrombosis: A phenomenological study The need for daily injections, compression garments, and medical follow-up adds to the burden during an already demanding period. Women recovering from milk leg often benefit from explicit mental health screening and support alongside the physical treatment.
The Cost of Treatment
Treatment decisions for severe DVT are increasingly being shaped by economic data. In the United States, estimated per-patient costs for acute DVT interventions vary considerably by technique. Mechanical thrombectomy was estimated at roughly $10,700 per episode, aspiration thrombectomy around $14,100, ultrasound-assisted catheter-directed thrombolysis about $16,200, and rheolytic thrombectomy near $19,700. The biggest cost driver across all approaches was the devices themselves, while thrombolytic drugs added substantial cost specifically for the catheter-directed techniques.15JVS-Vascular Insights. Inferring acute economic aspects of endovascular deep vein thrombosis management from a literature-based comparative cohort analysis These upfront numbers can look daunting, but they do not capture the full picture. When lifetime costs are modeled, including the years of managing post-thrombotic syndrome, compression garments, wound care, and lost productivity, the more aggressive early treatments can end up costing less overall than the cheaper initial strategy of anticoagulation alone.11PubMed. Cost Effectiveness of Mechanical Thrombectomy Versus Anticoagulation for Treating Iliofemoral Deep Vein Thrombosis in the UK
For patients, the practical takeaway is that asking about interventional options early in the course of a severe leg clot is worth doing, especially if the clot extends into the large iliac or femoral veins. Not every hospital has vascular specialists who perform these procedures, so access can be uneven. A transfer to a center with endovascular capabilities may be necessary, and time matters: the sooner clot is removed, the better the long-term outcomes tend to be.